Skip to main content

Chronic myeloid leukemia among veterans from 2006 to 2015: Trends in utilization of tyrosine kinase inhibitors

Publication ,  Conference
Chanfreau, C; Lynch, KE; Chang, JW; Becker, DJ; Friedman, DR; Rivera, DR; DuVall, SL; Lynch, JA
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
August 1, 2018

Duke Scholars

Published In

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

EISSN

1099-1557

ISSN

1053-8569

Publication Date

August 1, 2018

Volume

27

Start / End Page

102 / 103

Publisher

WILEY

Related Subject Headings

  • Pharmacology & Pharmacy
  • 4202 Epidemiology
  • 3214 Pharmacology and pharmaceutical sciences
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chanfreau, C., Lynch, K. E., Chang, J. W., Becker, D. J., Friedman, D. R., Rivera, D. R., … Lynch, J. A. (2018). Chronic myeloid leukemia among veterans from 2006 to 2015: Trends in utilization of tyrosine kinase inhibitors. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 27, pp. 102–103). WILEY.
Chanfreau, Catherine, Kristine E. Lynch, Ji Won Chang, Daniel J. Becker, Daphne R. Friedman, Donna R. Rivera, Scott L. DuVall, and Julie A. Lynch. “Chronic myeloid leukemia among veterans from 2006 to 2015: Trends in utilization of tyrosine kinase inhibitors.” In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 27:102–3. WILEY, 2018.
Chanfreau C, Lynch KE, Chang JW, Becker DJ, Friedman DR, Rivera DR, et al. Chronic myeloid leukemia among veterans from 2006 to 2015: Trends in utilization of tyrosine kinase inhibitors. In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY; 2018. p. 102–3.
Chanfreau, Catherine, et al. “Chronic myeloid leukemia among veterans from 2006 to 2015: Trends in utilization of tyrosine kinase inhibitors.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 27, WILEY, 2018, pp. 102–03.
Chanfreau C, Lynch KE, Chang JW, Becker DJ, Friedman DR, Rivera DR, DuVall SL, Lynch JA. Chronic myeloid leukemia among veterans from 2006 to 2015: Trends in utilization of tyrosine kinase inhibitors. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY; 2018. p. 102–103.

Published In

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

EISSN

1099-1557

ISSN

1053-8569

Publication Date

August 1, 2018

Volume

27

Start / End Page

102 / 103

Publisher

WILEY

Related Subject Headings

  • Pharmacology & Pharmacy
  • 4202 Epidemiology
  • 3214 Pharmacology and pharmaceutical sciences
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences